Impact of tremelimumab dosing and sequence on tumor immune microenvironment and efficacy of neoadjuvant chemotherapy in advanced ovarian cancer: Insights from the TRU-D/KGOG-3046 study

IF 4.1 2区医学 Q1 OBSTETRICS & GYNECOLOGY

Gynecologic oncology Pub Date : 2025-09-01 DOI:10.1016/j.ygyno.2025.03.087

Junsik Park , Je-Gun Joung , Eunhyang Park , Myong Cheol Lim , Byoung-Gie Kim , Jae-Weon Kim , So-Jin Shin , Sunghoon Kim , Chel Hun Choi , Hee Seung Kim , Sang Yoon Park , Jung-Yun Lee

引用次数: 0

查看原文本刊更多论文

tremelimumab剂量和序列对晚期卵巢癌肿瘤免疫微环境和新辅助化疗疗效的影响：来自trud /KGOG-3046研究的见解

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Gynecologic oncology 医学-妇产科学

CiteScore

8.60

自引率

6.40%

发文量

1062

审稿时长

37 days

期刊介绍： Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published. Research Areas Include: • Cell and molecular biology • Chemotherapy • Cytology • Endocrinology • Epidemiology • Genetics • Gynecologic surgery • Immunology • Pathology • Radiotherapy